Stryker (SYK)
(Delayed Data from NYSE)
$369.25 USD
-0.50 (-0.14%)
Updated Oct 16, 2025 04:00 PM ET
After-Market: $369.16 -0.09 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SYK 369.25 -0.50(-0.14%)
Will SYK be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SYK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SYK
J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
SYK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is J&J's MedTech Segment Set for Another Quarter of Growth?
SNN or SYK: Which Is the Better Value Stock Right Now?
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Other News for SYK
SYK forms 20 Day Moving Average Resistance on October 15
Price Over Earnings Overview: Stryker
Truist Securities Lowers Price Target for Stryker (SYK) | SYK Stock News
Stryker price target lowered to $407 from $415 at Truist
Stryker price target lowered by $8 at Truist, here's why